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H2AX Haploinsufficiency Modifies Genomic
Stability and Tumor Susceptibility
coding segments (V, D, and J gene segments) (reviewed
in Fugmann et al., 2000). The subsequent juxtaposition
and ligation of V(D)J ends requires ubiquitously ex-
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pressed DNA repair proteins (Ku80, Ku70, DNA-PKcs,Duane R. Pilch,4 Olga A. Sedelnikova,4
XRCC4, Ligase 4, and Artemis) that function in nonho-Michael Eckhaus,3 Thomas Ried,2
mologous end joining (NHEJ) (reviewed in Bassing etWilliam M. Bonner,4 and Andre´ Nussenzweig1,*
al., 2002b). The assembly of antigen receptor genes is1Experimental Immunology Branch
necessary to drive further development and expansion2 Genetics Branch
of lymphocyte precursors. V(D)J recombination is re-National Cancer Institute
stricted to the G0/G1 phase of the cell cycle (DesiderioNational Institutes of Health
et al., 1996), where NHEJ appears to be preferentiallyBethesda, Maryland 20892
active (Takata et al., 1998). Another distinct DNA repair3 Veterinary Resources Program
pathway, termed homologous recombination (HR), isOffice of Research Services
critical for resolving DSBs during meiotic recombinationNational Institutes of Health
(Paˆques and Haber, 1999) and in proliferating cells (So-Bethesda, Maryland 20892
noda et al., 1998). As such, loss of either NHEJ or HR4 Laboratory of Molecular Pharmacology
can lead to unresolved strand breaks, resulting in anNational Cancer Institute
arrest in lymphocyte development. Removal of p53-National Institutes of Health
dependent apoptotic function abolishes the block inBethesda, Maryland 20892
thymocyte expansion in T cells lacking the HR protein
Brca1; however, the surviving T cells harbor extensive
chromosomal aberrations and have an increased sus-
ceptibility to malignant transformation (Mak et al., 2000).Summary
In contrast, inactivation of p53 in NHEJ-deficient mice
does not restore lymphocyte development, but theseHistone H2AX becomes phosphorylated in chromatin
mice rapidly succumb to pro-B cell lymphomas (Guidosdomains flanking sites of DNA double-strand break-
et al., 1996; Nacht et al., 1996; Vanasse et al., 1999;age associated with -irradiation, meiotic recombina-
Difilippantonio et al., 2000; Frank et al., 2000; Gao et al.,tion, DNA replication, and antigen receptor rearrange-
2000; Lim et al., 2000) caused by the aberrant repair ofments. Here, we show that loss of a single H2AX allele
DSBs initiated at the IgH locus during V(D)J recombina-compromises genomic integrity and enhances the
tion (Difilippantonio et al., 2002; Zhu et al., 2002; Gladdysusceptibility to cancer in the absence of p53. In com-
et al., 2003). Even a modest reduction in NHEJ activityparison with heterozygotes, tumors arise earlier in the
results in chromosomal aberrations (Karanjawala et al.,H2AX homozygous null background, and H2AX/
1999), and loss of a single DNA Ligase4 allele sensitizesp53/ lymphomas harbor an increased frequency of
ink4a/arf/ mice to sarcomas (Sharpless et al., 2001).clonal nonreciprocal translocations and amplifica-
These results highlight the fact that physiologically gen-tions. These include complex rearrangements that jux-
erated DSBs are potent substrates for chromosomaltapose the c-myc oncogene to antigen receptor loci.
translocations and gene amplifications, which have theRestoration of the H2AX null allele with wild-type H2AX
potential to drive tumorigenesis when apoptosis is cir-restores genomic stability and radiation resistance,
cumvented. Hence, the immediate recognition and ap-but this effect is abolished by substitution of the con-
propriate resolution of DSBs is critical for maintaining
served serine phosphorylation sites in H2AX with ala-
genomic stability.
nine or glutamic acid residues. Our results establish Toward this end, thousands of histone H2AX mole-
H2AX as genomic caretaker that requires the function cules in the vicinity of the break are phosphorylated on
of both gene alleles for optimal protection against tu- serine residues (S136 and S139 in the mouse) located
morigenesis. within their unique C-terminal tail (reviewed in Redon
et al., 2002). H2AX phosphorylation (termed -H2AX) is
Introduction mediated by the phosphatidylinositol 3-kinase (PI-3K)-
like protein kinase family members ATM, ATR, and DNA-
The repair of DNA double-strand breaks (DSBs) is critical PK (Redon et al., 2002). -H2AX forms at sites of physio-
for preserving genomic integrity. Chromosomal breaks logical DSBs in lymphocytes (Chen et al., 2000; Petersen
arise accidentally as products of collapsed replication et al., 2001) and germ cells (Mahadevaiah et al., 2001;
forks or as programmed events during immune receptor Fernandez-Capetillo et al., 2003), and is induced in re-
rearrangements in lymphocytes and meiotic recombina- sponse to replication stress and external DNA damage
tion in germ cells. Antigen receptor diversification in (Rogakou et al., 1998; Ward and Chen, 2001; Redon et
lymphocytes is initiated by the RAG-1/2 endonuclease, al., 2002). Many known components of the DNA damage
which introduces DSBs adjacent to the antigen receptor response including Brca1, Nbs1/Mre11/Rad50, 53BP1,
MDC1, and Rad51 form foci that colocalize with preex-
isting -H2AX foci (Paull et al., 2000; Chen et al., 2000;*Correspondence: andre_nussenzweig@nih.gov
5These authors contributed equally to this work. Schultz et al., 2000; Rappold et al., 2001; Goldberg et
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al., 2003; Lou et al., 2003; Stewart et al., 2003). Moreover, (11.6 weeks, n  16) (H2AX/p53/ versus H2AX/
p53/, p  0.05; H2AX/p53/ versus H2AX/p53/,H2AX is required for the establishment of damage-
induced foci containing many of these factors (Celeste p  0.0001). Similar results have been obtained in
crosses between p53/ mice and an independently de-et al., 2002; Bassing et al., 2002a; Celeste et al., 2003;
Stewart et al., 2003). Defects in the organization of nu- rived H2AX/ mouse strain (Bassing et al., 2003 [this
issue of Cell]). H2AX/p53/ mice were susceptible pre-clear foci have been associated with impairment of nu-
merous responses to DSBs (Celeste et al., 2002; Bassing dominantly to T and B cell lymphomas (10/11 mice ana-
lyzed; Figure 1B), as determined by expression of cellet al., 2002a; Fernandez-Capetillo et al., 2002).
Although H2AX appears to modulate both HR and surface markers (Thy1.2, CD4 , CD8 , CD3, B220, CD19,
IgM, and CD43). Thymic lymphomas expressed Thy1.2,NHEJ, it is not an essential component of either DSB
repair pathway. For example, meiotic recombination is variable amounts of CD4 and/or CD8 and were low for
CD3, indicative of an immature T cell phenotype. Thenot grossly affected in H2AX/ mice (Fernandez-Cape-
tillo et al., 2003), although H2AX/ ES cells, like cells two B cell lymphomas were B220-, CD19-, and CD43-
positive, and negative for surface IgM (data not shown),deficient in the HR factor RAD54 (Essers et al., 1997),
are sensitive to DNA crosslinking agents and impaired and thus were similar to the pro-B cell tumors that con-
sistently develop in mice with dual impairments in p53in targeted integration (Celeste et al., 2002; Bassing et
al., 2002a). Likewise, elimination of the unique C-ter- and NHEJ (Guidos et al., 1996; Nacht et al., 1996; Va-
nasse et al., 1999; Difilippantonio et al., 2000; Frank etminal H2A serine residue in S. cerevisiae leads to only
a mild impairment in NHEJ activity (Downs et al., 2000). al., 2000; Gao et al., 2000; Lim et al., 2000). In contrast,
the tumor spectrum of H2AX/p53/ mice was broader,Immunoglobulin class-switch recombination, which is
also dependent on NHEJ, is defective in H2AX/ mice and included thymic lymphomas, sarcomas, leukemia,
and a brain tumor (Figure 1B). We conclude that partial(Celeste et al., 2002; Petersen et al., 2001; Reina-San-
Martin et al., 2003). Although lymphocyte development or complete loss of H2AX synergizes with p53 inactiva-
tion to promote tumorigenesis.and V(D)J recombination are largely intact, there is a
2-fold reduction in the absolute number of lymphocytes
in H2AX/ mice (Bassing et al., 2002a; Celeste et al., Chromosomal Aberrations in H2AX/p53/
2002). Despite the fact that H2AX is not essential for and H2AX/p53/ Lymphomas
NHEJ or HR, H2AX deficiency results in genomic insta- To clarify the mechanism by which H2AX deficiency
bility (Celeste et al., 2002; Bassing et al., 2002a). Consis- modifies cancer susceptibility, we examined metaphases
tent with this observation, the H2AX locus maps to chro- from p53/, H2AX/p53/, and H2AX/p53/ lympho-
mosome 11q23.3, a region that is commonly deleted in mas by spectral karyotype analysis (SKY). As previously
human lymphoid and solid tumors (Monni and Knuutila, reported (Difilippantonio et al., 2002), p53/ lymphomas
2001). In this study, we investigate the role of H2AX in were near tetraploid and rarely harbored clonal chromo-
tumorigenesis using a mouse model system. somal translocations (average: 0.3 translocations/tu-
mor) (Figures 2A and 2B). In contrast, the majority of
H2AX/p53/ lymphomas were near diploid and har-Results
bored nonreciprocal clonal rearrangements as well as
numerous dicentric chromosomes and centromere fu-Deficiency in H2AX and p53 Cooperate
in Tumorigenesis sions, referred to as Robertsonian (Rb) translocations
(Figures 2A and 2B, Table 1). In one of the four casesInitially, a cohort of H2AX/, H2AX/, and H2AX/ mice
was monitored over a period of 1.5 years. None of the analyzed, telomeric signals remained at the site of fusion
(data not shown). H2AX/p53/ lymphomas were gen-H2AX/ (n  17), H2AX/ (n  36), or H2AX/ (n  34)
mice in this aged population developed tumors (Figure erally polyploid but the number of chromosomes gained
was less than in p53/ lymphomas (Figures 2A and 2B,1A). H2AX/ peripheral T lymphocytes, however, were
found to harbor both random breaks and translocations, Table 1). In addition, on average fewer clonal transloca-
tions were found in H2AX/p53/ lymphomas than insome of which involved the antigen receptor loci (Ce-
leste et al., 2002). Given the normal health and lifespan H2AX/p53/ tumors (Figure 2B and Table 1; 1.3 and
2.3, respectively). Thus, the extent of structural and nu-of these animals, we speculated that the observed chro-
mosomal rearrangements in H2AX/ lymphocytes (Ce- merical aberrations in H2AX/p53/ lymphomas was
intermediate between that observed in H2AX/p53/leste et al., 2002) were insufficient to promote tumori-
genesis and that cells harboring unresolved broken and H2AX/p53/ mice.
In order to assess the consequences of the observedchromosomes with the potential to form oncogenic
translocations would normally be eliminated in vivo numerical aberrations with respect to genomic imbal-
ances, we used comparative genomic hybridizationthrough the activation of p53-dependent apoptosis.
To test this hypothesis, we crossed all H2AX geno- (CGH), a technique that samples the entire tumor popu-
lation, to assess gains and losses relative to the mosttypes onto a p53/ background. Loss of one or both
alleles of H2AX decreased the average tumor latency of prevalent chromosome ratio (Weaver et al., 1999). CGH
analysis revealed very distinct common gains of wholep53/ mice (Figure 1A). The onset of death was 8 weeks
for H2AX/p53/ mice, 10 weeks for H2AX/p53/ chromosomes or parts of chromosomes 4, 5, 11, and
15 and loss of 19 in thymic lymphomas from p53/mice, and 18 weeks for H2AX/p53/ mice. Moreover,
the median survival time of H2AX/p53/ mice (23.4 mice irrespective of the H2AX genotype (Figure 3). The
minimal overlapping regions affected were chromosomeweeks, n  21) was significantly longer than either
H2AX/p53/ (17 weeks, n 47) or H2AX/p53/ mice bands 4C7-D2.2, 5F-G2, 11E1-E2, 15D1-D3, and 19D2-
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Figure 1. H2AX and p53 Deficiency Synergize in Tumorigenesis
(A) Survival curves for H2AX/, H2AX/, H2AX/, H2AX/p53/, H2AX/p53/, and H2AX/p53/ mice. H2AX/, H2AX/, and H2AX/
mice (indicated by large diamond) exhibited a tumor free survival for at least 50 weeks. Percent survival is plotted as a function of time in
weeks. Number of mice analyzed is indicated.
(B) Tumor spectrum in 15 H2AX/p53/ and 11 H2AX/p53/ mice. Four H2AX/p53/ mice died of unknown causes (data not shown).
D3. In general, the gains in H2AX/p53/ tumors tended coamplified IgHC and c-myc sequences (Figure 4, Ta-
ble 1; see also Supplemental Figures S1A and S1B onlineto be entire chromosomes while those in the H2AX/
p53/ thymic lymphomas had more regional gains, con- at http://www.cell.com/cgi/content/full/114/3/371/DC1).
For both tumors, the breakpoint occurred more thansistent with an increase in chromosomal translocations
detected by SKY analysis (Figure 2 and Table 1). Despite 440 kb 3 of c-myc (Supplemental Figure S1C). These
cytogenetic features of H2AX/p53/ pro-B cell lym-differences in structural chromosomal aberrations and
aneuploidy (Figure 2), a similar nonrandom pattern of phomas are the hallmarks of RAG-dependent lympho-
mas that invariably develop in NHEJ-/p53-deficient micechromosomal imbalances was found among all H2AX
genotypes (Figure 3). Therefore, we hypothesize that (Difilippantonio et al., 2002; Zhu et al., 2002; Gladdy et
al., 2003). However, while NHEJ-/p53-deficient pro-Bthe accelerated age of onset of cancer concordant with
decreasing amounts of H2AX is due to the increased cell lymphomas contain short homologies directly at the
ability to acquire the minimal set of chromosomal trans- translocation junctions (Difilippantonio et al., 2002; Zhu
locations necessary for tumor development. et al., 2002), the cloned chromosome 12 and 15 fusion
from tumor 3092 did not have sequence homology im-
mediately at the junction (Supplemental Figure S1D),H2AX Monitors Chromosomal Breaks
suggesting that this joining may have been mediated byduring Lymphocyte Development
classical NHEJ. These results are similar to the analysisIn NHEJ-/p53-deficient lymphomas, oncogenic translo-
of translocation breakpoints in pro-B cell lymphomascations arise as byproducts of aberrant V(D)J recombi-
from an independently derived H2AX/p53/ mousenation (Difilippantonio et al., 2002; Gladdy et al., 2003;
strain (Bassing et al., 2003). Thus, H2AX and p53 cooper-Zhu et al., 2002). To determine whether DNA rearrange-
ate to limit the oncogenic potential of DSBs during anti-ments in H2AX/p53/ mice juxtaposed oncogenes
gen receptor rearrangements, a finding that is consis-with antigen receptor loci, we analyzed metaphase
tent with the localization of -H2AX to sites of V(D)Jspreads using a combination of whole chromosome
recombination (Chen et al., 2000).painting probes together with probes for c-myc, IgHC,
Amplification of IgH/c-myc in NHEJ-/p53-deficient tu-and TCR genes, which reside on chromosomes 15,
mors is driven via breakage-fusion-bridge (BFB) cycles12, and 14, respectively. Both pro-B cell lymphomas
initiated by aberrant processing of RAG-induced DSBs(designated 3092 and 2274) contained a recurrent T(12;
(Difilippantonio et al., 2002; Zhu et al., 2002; Gladdy et15) translocation with the distal portion of chromosome
al., 2003). Based on CGH, the largest region involved in15 fused to the derivative chromosome 12, and an IgHC
the duplication/amplification of chromosome 12 oc-signal near the breakpoint (Figure 4). In addition, these
tumors exhibited complex translocations that contained curred in tumor 2274 (Figure 3). This was approximately
Cell
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Figure 2. Structural and Numerical Aberrations in H2AX/p53/, H2AX/p53/, and H2AX/p53/ Lymphomas
(A) SKY analysis of H2AX/p53/ (left), H2AX/p53/ (middle), and H2AX/p53/ (right) thymic lymphomas. Structural aberrations include
dicentric (dic) chromosomes, Robertsonian (Rb) fusions, and translocations (T). The total number of chromosomes counted in the metaphase
spread is indicated in the lower left-hand corner.
(B) Average number of clonal translocations (left bar graph) and average chromosome number (right bar graph) in H2AX/p53/ (n  10
tumors), H2AX/ p53/ (n  6), and H2AX/p53/ (n  3) lymphomas.
45 Mb in size occurring roughly between nucleotide not shown). However, one of the H2AX/p53/ thymic
lymphomas (2280) harbored clonal rearrangements in-position 62,000,000 (band D2) and 107,000,000 (band
F2 containing the IgH locus). In tumor 3092, the region volving chromosome 14 in the vicinity of the TCR locus
(Table 1). Moreover, on the T(15;14) chromosome, theof chromosome 12 gained (25Mb) was between
82,000,000 (band E) and 107,000,000 (band F2). In 3092 TCR gene colocalized precisely with c-myc at the
breakpoint, but neither gene appeared amplified as inthe gain observed on chromosome 15 was larger than
in 2274, and was approximately 20 Mb from the middle the pro-B cell lymphomas (Figure 4). FISH mapping,
using two BAC probes 96F18 and 212H11 (Difilippan-of band D1 (46,000,000) to D3 (66,000,000). For tumor
2274 the area on chromosome 15 near c-myc that was tonio et al., 2002), revealed that the breakpoint on chro-
mosome 15 was within 200 kb telomeric of c-myc. Thus,amplified (as seen by FISH and Southern blot; Supple-
mental Figure S1) was below the limit of resolution of tumorigenesis in H2AX/p53/ mice can be caused ei-
ther by failure to correctly repair RAG-mediated DSBsmouse chromosome CGH (4 Mb). The variations in the
boundaries as well as the number of copies of the ampli- or via other physiological breaks that might arise sponta-
neously during DNA replication.fied sequences are likely to depend on where the breaks
occur and the number of cycles of BFB (Coquelle et al.,
1997). Although activation of fragile sites may determine Loss of One H2AX Allele Compromises
Genomic Integritythe boundaries of amplification (Coquelle et al., 1997),
the heterogeneity in the distance between amplified If H2AX behaved as a canonical tumor suppressor, loss
of the second H2AX allele would be expected in H2AX/units (Supplemental Figure S1) argues against a single
site of breakage being utilized for the resolution of the p53/ tumors. However, the wild-type allele remained
intact in all of the tumors tested (n  4), as determinedbridge during BFB cycles.
Primary H2AX/ T lymphocytes carry both random by Western blotting analysis of -H2AX (Supplemental
Figure S2). An alternative explanation for why one copychromosomal rearrangements and more rarely TCR-
associated translocations (Celeste et al., 2002). Consis- of H2AX can synergize with p53 inactivation to promote
tumorigenesis is that the efficiency of DSB signalingtent with this, the majority of H2AX/p53/ thymomas
analyzed (n  6) harbored clonal translocations without through H2AX phosphorylation is decreased in H2AX/
mice. Support for this hypothesis comes from Westernthe involvement of antigen receptor loci (Table 1; data
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Figure 3. CGH Analysis of H2AX/p53/, H2AX/p53/, and H2AX/p53/ Lymphomas
Summary of CGH analysis using genomic DNA from a H2AX/p53/ thymic lymphoma: designated 2976; four H2AX/p53/ thymic lympho-
mas: 1, 3014; 2, 3022; 3, 3070; 4, 3149; and eight H2AX/p53/ thymic lymphomas: 1, 2280; 2, 2929; 3, 2968; 4, 3009; 5, 3143; 6, 3148; 7,
3150; and 8, 3154; and two H2AX/p53/ pro-B cell lymphomas: 1, 2274; and 2, 3092. Green bars on the right side of the ideograms indicate
chromosome gains and red bars on the left side indicate chromosome losses. Thick bars (e.g., IgH locus in tumor 2274) indicate high-level
amplification. All gains and losses for a single tumor are represented in numerical order equidistant from the individual chromosome ideogram.
The chromosomal position of the IgH and c-myc loci is indicated in the pro-B cell lymphoma CGH map.
blot analysis in which primary H2AX/ thymocytes MEFs (Figure 5D). Thus, H2AX haploinsufficiency results
in genomic instability.clearly expressed less than the normal content of un-
phosphorylated and phosphorylated H2AX (Figure 5A). Defects in DSB repair are associated with decreased
proliferation in vitro and radiation sensitivity (Barlow etTo determine whether H2AX haploinsufficiency af-
fects chromosomal stability, we examined metaphase al., 1996; Nussenzweig et al., 1996). Consistent with an
increased genomic instability, primary H2AX/ MEFsspreads derived from T cells isolated from two indepen-
dent sets of H2AX/, H2AX/, and H2AX/ littermates. exhibited a longer population doubling time than
H2AX/ controls (Figure 5E), and H2AX/ ES cells ex-H2AX/ T cells (n  100) exhibited excess numbers of
chromosome breaks, fragments, and fusions relative to hibited an intermediate sensitivity to agents that cause
DSBs (Supplemental Figure S3). Loss of p53 only par-H2AX/ cells (n 100) and approximately half as many
aberrations as in H2AX/ T cells (n  100) (Figure 5B). tially alleviated the growth defects in H2AX/ MEFs (Fig-
ure 5E). This is in contrast to the complete rescue ofSimilarly, the average number of chromosomal aberra-
tions in primary fibroblast cultures from H2AX/p53/ proliferation defects in Ku80/p53/ and Xrcc4/p53/
MEFs (Difilippantonio et al., 2000; Frank et al., 2000) butmice (1.2) was intermediate between that found in
H2AX/p53/ (0.37) and H2AX/p53/ (2.1) MEFs (Fig- similar to the partial rescue observed in ATM/p53/
MEFs (Xu et al., 1998). Like their p53-wild-type counter-ure 5C). Treatment with 0.5-1.5 Gy of -irradiation further
increased the number of chromosomal aberrations (Fig- parts, primary H2AX/p53/ MEFs exhibited a longer
doubling time and were more sensitive than H2AX/ure 5C). Asymmetric chromatid-type exchanges, which
are the result of the fusions between two or more broken p53/ MEFs to ionizing radiation (Figures 5E and 5F).
In total, these in vitro results demonstrate that the levelchromatids, were prominent in H2AX/p53/ and H2AX/
p53/ MEFs but were rarely found in irradiated p53/ of DNA damage, rates of cellular proliferation, and radia-
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Figure 4. Fusions of the c-myc Oncogene to Antigen Receptor Loci in H2AX/p53/ B and T Cell Lymphomas
Top: SKY analysis of H2AX/p53/ pro-B cell (3092 and 2274) and thymic (2280) lymphomas. Translocations in pro-B and T cell lymphomas
are similar to those observed in NHEJ-/p53-deficient lymphomas and ATM/ thymomas respectively. Bottom: FISH analysis using chromosome
12, 15, and 14 painting probes combined with locus- (IgHC, c-myc, and TCR) specific probes. IgH and c-myc are juxtaposed and amplified
(indicated by three arrows) in the pro-B cell lymphomas, and TCR/c-myc are fused at the T(15; 14) translocation breakpoint in the thymic
lymphoma.
tion sensitivity are proportional to the gene dosage of the wild-type reconstituted H2AX/p53/ lines were at
least 3.5-fold higher than in H2AX/p53/ lines (35%–H2AX. This is consistent with the earlier onset and in-
creased frequency of chromosome translocations ob- 40% of the total H2A content versus 10%, respectively),
but this overexpression did not affect the populationserved in tumors from H2AX/p53/ versus H2AX/
p53/ mice. doubling time or irradiation-induced survival (Supple-
mental Figure S4; Figure 6B). In marked contrast, substi-
tution of H2AX serine residues by either alanine or glu-Phosphorylation of H2AX Is Critical
for Maintaining Genomic Stability tamic acid failed to rescue the chromosomal defects
observed in the parental H2AX/p53/ cells (Figure 6A).To identify the functional domains of H2AX required for
maintaining genomic stability, we simultaneously mu- Furthermore, both S136/S139A and S136/139E mutant
lines were still sensitive to -irradiation (Figure 6B), andtated the SQ motifs (S136/S139) in the C terminus to
either alanine (S136/139A) to eliminate phosphorylation failed to form IRIF (Figure 6C) (Celeste et al., 2003). Thus,
the placement of negatively charged residues in theor to glutamic acid (S136/139E) to mimic constitutive
phosphorylation (Downs et al., 2000). Immortalized COOH-terminal tail does not mimic constitutive phos-
phorylation. Rather, radiation resistance, foci formation,H2AX/p53/ MEFs were reconstituted with either wild-
type, S136/S139A, or S136/139E H2AX constructs (Ce- and genomic integrity require the specific transfer of
phosphate groups to serine 136/139 in H2AX.leste et al., 2003). Restoration of H2AX with the wild-
type transgene significantly decreased the amount of
spontaneous and ionizing radiation-induced DNA dam- Discussion
age observed in metaphases spreads (Figure 6A). Con-
sistent with reconstitution of H2AX function, both the We have shown that H2AX phosphorylation is critical
for protecting the genome from spontaneous-, irradia-irradiation-induced survival (Figure 6B) and the ability
to form 53BP1, Brca1 (Figure 6C), and Nbs1 irradiation- tion- and V(D)J recombination-induced DSBs. In con-
cordance with this, the observed phenotypes tightlyinduced foci (IRIF) (Celeste et al., 2003) were rescued
by the addition of wild-type H2AX. Levels of H2AX in correlate with H2AX phosphorylation at sites of DSBs,
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Figure 5. Loss of One Copy of H2AX Leads to Genomic Instability
(A) Western blot analysis of H2AX (left) and -H2AX (right) protein in H2AX/, H2AX/, and H2AX/ thymocytes before (C) and 30 min after
treatment with 10 Gy -irradiation (IR). Nbs1 protein levels are shown below as loading controls. The position of phosphorylated Nbs1 relative
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irrespective of their origin (Chen et al., 2000; Mahade- in susceptibility to B cell lymphomas of a more advanced
developmental stage than observed in the context ofvaiah et al., 2001; Petersen et al., 2001; Rogakou et al.,
1998; Ward and Chen, 2001). -H2AX is associated with NHEJ/p53 deficiency. Consistent with this, Bassing et
al. (2003) have observed H2AX-/p53-deficient B cell lym-nuclear foci containing factors that are essential for DNA
repair, replication, and cell cycle regulation. Although phomas harboring breakpoints in the vicinity of the
switch regions.focus formation is dependent on H2AX phosphorylation,
H2AX/ mice exhibit a relatively mild phenotype. Although H2AX, as a histone, probably does not di-
rectly mediate enzymatic DNA repair, it clearly plays aH2AX/ mice are viable and show modest sensitivity to
-irradiation and impairment in class-switch recombina- critical role in suppressing oncogenic translocations.
H2AX phosphorylation at Ser136/139 does not providetion but display no detectable abnormalities in the for-
mation of V(D)J recombination signal or coding joints the initial signal that attracts proteins to damaged DNA
(Celeste et al., 2003). However, once repair proteins have(Celeste et al., 2002; Bassing et al., 2002a). However,
since only productive V(D)J joints are selected for during migrated to DSBs, the phosphorylated residues on
H2AX may serve as docking sites for the assembly oflymphocyte development, subtle defects in the capacity
to repair DSBs during V(D)J recombination (or DNA repli- proteins in chromatin regions distal to the lesion, re-
sulting in the formation of nuclear foci. A high concentra-cation) would be difficult to detect. The 50% reduction in
the absolute number of T and B lymphocytes in H2AX/ tion of proteins in a locally damaged chromatin domain
may facilitate the repair of a critical subset of (persistent)mice (Celeste et al., 2002) bolsters the idea that there is
a reduced efficiency in the repair of RAG- or replication- lesions, which might otherwise be substrates for aber-
rant recombination reactions. For example, H2AX phos-induced lesions, and that those H2AX/ cells harboring
genome-destabilizing chromosome breaks are elimi- phorylation and its associated foci may directly modu-
late the higher order chromatin structure in a mannernated in vivo. Our demonstration that H2AX deficiency
synergizes with p53 inactivation to promote tumorigene- that keeps the broken DNA ends tethered together. In
our irradiation experiments, we found that reducing thesis strongly supports this hypothesis.
The T(12;15) rearrangement and coamplification of amount of H2AX increases the propensity for asymmet-
ric chromosomal interchanges. This could be explainedc-myc/IgH in pro-B cell lymphomas from H2AX/p53/
and NHEJ-/p53-deficient mice (Difilippantonio et al., by a failure to keep the ends in close proximity long
enough for them to be re-ligated. The availability of these2002; Zhu et al., 2002; Gladdy et al., 2003) are strikingly
similar. By contrast, it was surprising that only 1 of 14 ends to recombine with broken ends from other chromo-
somes would result in translocations. According to thisH2AX-/p53-deficient thymic lymphomas contained a
translocation involving the TCR and c-myc) loci. We model, -H2AX might be more critical for the response
to spontaneous DSBs than during programmed V(D)Jspeculate that the majority of translocations observed
in H2AX/T cells arose via misrepair of replicative DSBs recombination, where tethering by the RAG-1/-2 pro-
teins facilitate efficient and rapid rejoining of brokenduring the rapid expansion of thymocyte precursors
rather than during V(D)J recombination. Consistent with DNA intermediates in a postcleavage synaptic complex
(Agrawal and Schatz, 1997; Hiom and Gellert, 1998).this, we have shown an accumulation of DSBs and
chromosomal abnormalities in cultured H2AX/ and While it is unclear precisely how chromatin remodeling
facilitates normal DNA repair, there is mounting evi-H2AX/ T cells. Interestingly, chromosome breaks were
not detected in H2AX/ B cells stimulated to undergo dence that -H2AX promotes changes in the structural
configuration of chromatin (Downs et al., 2000; Fernan-class-switch recombination, despite the fact that class
switching is reduced in the absence of H2AX (Reina- dez-Capetillo et al., 2003; Reina-San-Martin et al., 2003).
Thus, chromatin reorganization by -H2AX could pre-San-Martin et al., 2003). We find that p53 deficiency
does not rescue the H2AX/ class-switching defect vent the premature separation of broken ends, a function
that would safeguard against potentially tumorigenic(Supplemental Figure S5); however, an increased fre-
quency of H2AX/p53/ B cells (13%) exhibited breaks chromosome rearrangements.
Tumor suppressor genes have been classified intoor translocations, some in the vicinity of the IgH locus
(Supplemental Figure S5). Based on these results, we two groups: gatekeepers and caretakers (Kinzler and
Vogelstein, 1997). Gatekeepers are involved in limitingwould predict that H2AX/p53 deficiency should result
to the unphosphorylated form is noted with arrows (upper and lower, respectively).
(B) Lymph node T cells from H2AX/, H2AX/, and H2AX/ littermates were cultured for 2 days, and metaphase spreads were examined
for chromosomal aberrations. A total of 100 metaphases from two mice of each genotype were scored.
(C) Passage 1 MEFs were either untreated or irradiated with graded doses of -irradiation, and metaphases were prepared 16 hr later. Average
number of chromosome aberrations (breaks, fragments, and exchanges) is plotted. For each dose, at least 30 metaphases were examined
for each genotype.
(D) Examples of metaphases from H2AX/p53/, H2AX/p53/, and H2AX/p53/ passage 1 MEFs after treatment with 1 Gy (top) and
5 Gy (lower panels) -irradiation. Arrowheads, chromosome type aberrations; arrows, chromatid type aberrations.
(E) Growth kinetics of H2AX/, H2AX/, H2AX/, H2AX/p53/, H2AX/p53/, and H2AX/p53/ MEFs at passage 1. The cell number is
an average of duplicates from two independent cells lines of each genotype. The slopes (number of cells per day), calculated from early time
points in curves, were: H2AX/, 8.67  105; H2AX/, 4.88  105; H2AX/, 3.10  104; H2AX/p53/, 9.98  105; H2AX/p53/, 5.11  105;
and H2AX/p53/, 2.22  105.
(F) Radiation sensitivity of H2AX/p53/, H2AX/p53/, and H2AX/p53/ passage 1 MEFs, plotted as a fraction of surviving cells relative
to unirradiated samples of the same genotype. Data were obtained from an average of duplicates from two independent cell lines.
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Figure 6. Phosphorylation of H2AX at Serine 136 and 139 Is Essential for Maintaining Genomic Integrity, Radiation Resistance, and Irradiation-
Induced Foci Formation
(A) Average number of chromosome aberrations in untreated and irradiated H2AX/p53/cells and H2AX/p53/ cells reconstituted with
wild-type H2AX (H2AX wt), serine to alanine substituted H2AX (H2AX S136/139A), and serine to glutamic acid substituted H2AX (H2AX
S136/139E). For each dose and genotype, at least 50 metaphases were examined.
(B) Radiation sensitivity of immortalized reconstituted lines plotted as a fraction of surviving cells relative to unirradiated samples of the same
genotype. The calculated survival represents the average from two independent cell lines (H2AX/p53/, DKO13 and DKO15; H2AX/p53/,
PW4 and PW16; H2AX wt, R6 and R20; H2AX S136A/S139A, A7 and A8; and H2AX S136E/S139E, E2 and E5) of each genotype.
(C) 53BP1 (green) and Brca1 (red) staining pattern in reconstituted lines 2 hr after treatment with 10 Gy irradiation. Images were merged (right)
to determine colocalization. The wild-type, but not the serine to glutamic acid or serine to alanine reconstituted lines, restores 53BP1 and
Brca1 foci formation. Similar results were obtained at 6 hr postirradiation.
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monoclonal Brca1 antibodies was performed as described (Celestecell growth and survival, whereas caretakers are DNA
et al., 2002, 2003).repair genes whose inactivation leads to genetic alter-
ations including mutations, rearrangements, and gene
Histopathological and Flow Cytometric Analysis of Tumors
amplifications. Although haploinsufficiency is predicted Mice were examined daily for evidence of morbidity. Tissues were
to be a common feature of cancer susceptibility genes fixed, sectioned, stained, and examined by light microscopy. Single-
(Cook and McCaw, 2000; Quon and Berns, 2001), the cell suspensions from lymphomas were stained for various lineage
specific cell surface markers (B220, Thy1.2, CD3, CD4, CD8, CD19,majority of known haploinsufficient tumor suppressors
CD43, and IgM) and analyzed by flow cytometry as described (Nus-are gatekeepers (Bai et al., 2003; Cook and McCaw,
senzweig et al., 1996).2000; Fero et al., 1998; Goss et al., 2002; Alt et al., 2003;
Gruber et al., 2002; Inoue et al., 2001; Magee et al., 2003; Southern Blotting, Spectral Karyotyping, FISH,
Quon and Berns, 2001; Venkatachalam et al., 1998). and CGH Analysis
H2AX modulates DSB repair, and tumorigenesis is Southern blotting was performed as described (Difilippantonio et
al., 2000; Zhu et al., 2002) using Jh4, c-myc, and 3IgH RR (3 ofsynergistically enhanced in H2AX/p53/ mice, even
C) probes. Mitotic chromosome spreads from primary passagethough H2AX levels are 50% of wild-type. The resultant
1 MEFs (H2AX/, H2AX/ H2AX/, H2AX/p53/, H2AX/p53/,decrease in -H2AX formation is insufficient to maintain
and H2AX/p53/), immortalized MEFs (H2AX/p53/ and H2AX/
genomic stability and leads to increased levels of chro- p53/ MEFs reconstituted with serine mutant forms of H2AX), pri-
mosomal aberrations, reduced growth rates, and radia- mary T and B cells, and lymphomas were prepared as described
tion sensitivity. Thus, histone H2AX is a caretaker that (Celeste et al., 2002). Spectral karyotype (SKY) was performed as
described (Liyanage et al., 1996). For FISH analysis, metaphasesdoes not conform to Knudson’s classic two-hit model
were hybridized with BAC probes for the following regions: IgHC,of tumor suppression (Knudson, 1985).
c-myc, TCR, and the breakpoint region on chromosome 15 pre-We have found that combined deficiency in H2AX and
viously identified in Ku/p53/ pro-B cell lymphomas (96F18 and
p53 in mice results in both lymphoid and solid tumors. 212H11) (Difilippantonio et al., 2002). Flow-sorted single chromo-
Interestingly, the histone H2AX gene, located 11 Mb somes were used for painting probes as described (Difilippantonio
telomeric to ATM at 11q23.3, is in a region commonly et al., 2002). A telomere repeat-specific peptide nucleic acid (PNA)
probe labeled with Cy3 (Applied Biosystems, Framingham, MA) wasdeleted or translocated in several human hematological
hybridized and detected as described (Difilippantonio et al., 2002).malignancies and solid tumors (Monni and Knuutila,
The mouse CGH hybridization protocol followed that of Weaver et2001). Heterozygous deletion of chromosome bands
al. (1999).
11q22-q23 is detected at a particularly high frequency
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